BE890192A - Compositions et procede pharmaceutiques - Google Patents

Compositions et procede pharmaceutiques

Info

Publication number
BE890192A
BE890192A BE0/205848A BE205848A BE890192A BE 890192 A BE890192 A BE 890192A BE 0/205848 A BE0/205848 A BE 0/205848A BE 205848 A BE205848 A BE 205848A BE 890192 A BE890192 A BE 890192A
Authority
BE
Belgium
Prior art keywords
methods
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
BE0/205848A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE890192A publication Critical patent/BE890192A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G55/00—Compounds of ruthenium, rhodium, palladium, osmium, iridium, or platinum
    • C01G55/002—Compounds containing ruthenium, rhodium, palladium, osmium, iridium or platinum, with or without oxygen or hydrogen, and containing two or more other elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/74—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by peak-intensities or a ratio thereof only
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/51—Particles with a specific particle size distribution
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
BE0/205848A 1979-10-02 1981-09-02 Compositions et procede pharmaceutiques BE890192A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/081,301 US4302446A (en) 1979-10-02 1979-10-02 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BE890192A true BE890192A (fr) 1982-03-02

Family

ID=22163311

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/205848A BE890192A (fr) 1979-10-02 1981-09-02 Compositions et procede pharmaceutiques

Country Status (12)

Country Link
US (2) US4302446A (enExample)
JP (1) JPS5832029A (enExample)
AT (1) AT375326B (enExample)
AU (1) AU551710B2 (enExample)
BE (1) BE890192A (enExample)
CA (1) CA1152289A (enExample)
CH (1) CH647216A5 (enExample)
DE (1) DE3133443A1 (enExample)
FR (1) FR2511357B1 (enExample)
GB (1) GB2103591B (enExample)
NL (1) NL8103784A (enExample)
SE (2) SE450830B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
DE3305248C2 (de) * 1983-02-16 1987-04-09 Degussa Ag, 6000 Frankfurt Verfahren zur Reinigung von cis-Platin-(II)-diammin-dichlorid
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
US4699978A (en) * 1985-01-18 1987-10-13 The Trustees Of Columbia University In The City Of New York Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
US4686104A (en) * 1985-04-30 1987-08-11 Sloan-Kettering Institute For Cancer Research Methods of treating bone disorders
JPS61293655A (ja) * 1985-05-31 1986-12-24 Trinity Ind Corp 砂型鋳造品の砂落し装置
CS269719B1 (en) * 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
JP2657393B2 (ja) * 1988-05-18 1997-09-24 日本化薬株式会社 化学塞栓療法剤
FI895340A7 (fi) * 1988-11-14 1990-05-15 Bristol Myers Squibb Co Hypertoninen cisplatin-liuos
US4946689A (en) * 1988-11-23 1990-08-07 Bristol-Myers Company Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
WO1998029344A1 (fr) * 1996-12-25 1998-07-09 Nippon Kayaku Kabushiki Kaisha Poudre de cisplatine fine et son procede de production
US6074626A (en) * 1998-03-20 2000-06-13 Molecular Radiation Management, Inc. Radioactive cisplatin in the treatment of cancer
HK1049787B (en) 1999-10-01 2014-07-25 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
RU2186068C2 (ru) * 1999-12-02 2002-07-27 Институт химии и химической технологии СО РАН Способ очистки цис-дихлороамминизопропиламинплатины (ii)
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
ES2277301T3 (es) * 2000-04-24 2007-07-01 Teva Pharmaceutical Industries Ltd. Solvato de hemitartrato de zolpidem.
EP1600159A1 (en) 2000-04-24 2005-11-30 Teva Pharmaceutical Industries Ltd A method for synthesizing different Zolpidem hemitartrate derivatives
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
EP1435963A4 (en) * 2001-09-24 2005-10-26 Tosk Inc CISPLATIN FORMULATIONS WITH REDUCED TOXICITY AND USE METHOD THEREFOR
DE602004028585D1 (de) * 2003-03-15 2010-09-23 Brin Tech Internat Ltd Verpackung für Arzneimittel
RU2343913C2 (ru) * 2003-03-31 2009-01-20 Плива-Лахема А.С. Фармацевтическая композиция, содержащая комплекс платины в качестве активного вещества, и способ ее получения
ES2284068T3 (es) * 2003-10-16 2007-11-01 Teva Pharmaceutical Industries Limited Preparacion de candesartan cilexetilo.
DE602005004966T2 (de) * 2004-01-05 2009-03-12 Teva Pharmaceutical Industries Ltd. Prozesse zur herstellung von sildenafil-base und zitratsalz
EP1713795A2 (en) * 2004-02-11 2006-10-25 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
RU2292210C1 (ru) * 2005-05-03 2007-01-27 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Способ получения стерилизованной микрокристаллической цис-дихлородиамминплатины (ii)
US20080085882A1 (en) * 2006-08-18 2008-04-10 University Of North Texas Health Science Center At Fort Worth Compositions and Methods for Potentiation of Cancer Agents
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) * 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
RU2009133447A (ru) * 2007-02-09 2011-03-20 Пониард Фармасьютикалз, Инк. (Us) Дозированная форма пикоплатина
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
JP2010533714A (ja) * 2007-07-16 2010-10-28 ポニアード ファーマシューティカルズ， インコーポレイテッド ピコプラチンのための経口製剤
CN102006875A (zh) * 2008-02-08 2011-04-06 帕纳德制药公司 吡铂和贝伐单抗治疗结直肠癌的用途
EP2249825B1 (en) 2008-03-14 2015-10-07 Bionumerik Pharmaceuticals, Inc. Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions
AU2008352603B2 (en) 2008-03-14 2012-05-31 Bionumerik Pharmaceuticals, Inc. Compositions and methods of use of compounds to increase cancer patient survival time
US20100035853A1 (en) * 2008-08-07 2010-02-11 Hyogo College Of Medicine Method for preventing or treating cisplatin-induced nephrotoxicity
RU2421231C1 (ru) * 2010-03-15 2011-06-20 Учреждение Российской академии наук Институт химии и химической технологии Сибирского отделения РАН (ИХХТ СО РАН) Способ получения стерилизованной микрокристаллической соли цис-дихлороамминэтиламинплатины (ii)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079121A (en) * 1974-12-13 1978-03-14 Mobil Oil Corporation Complexes of beta platinum chloride and ammonia
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes

Also Published As

Publication number Publication date
FR2511357A1 (fr) 1983-02-18
GB2103591A (en) 1983-02-23
FR2511357B1 (fr) 1986-09-05
CA1152289A (en) 1983-08-23
AU7390681A (en) 1983-02-10
SE450830B (sv) 1987-08-03
JPH0313174B2 (enExample) 1991-02-21
SE8300623D0 (sv) 1983-02-07
CH647216A5 (de) 1985-01-15
AT375326B (de) 1984-07-25
SE8104661L (sv) 1983-02-04
JPS5832029A (ja) 1983-02-24
NL8103784A (nl) 1983-03-01
DE3133443A1 (de) 1983-03-10
ATA374981A (de) 1983-12-15
US4302446A (en) 1981-11-24
AU551710B2 (en) 1986-05-08
SE8300623L (sv) 1983-02-07
US4322391A (en) 1982-03-30
SE455469B (sv) 1988-07-18
GB2103591B (en) 1985-03-06

Similar Documents

Publication Publication Date Title
BE890192A (fr) Compositions et procede pharmaceutiques
PT72049B (pt) Imidazole-5-acetic acid derivatives their production and use
FI803767L (fi) Cortikosteroid innehaollande farmaceutiska blandningar
BE877393A (fr) Phenethanolamines et compositions pharmaceutiques en contenant
BE855032A (fr) Compositions pharmaceutiques pour opacification barytee et leur procede de preparation
BE871584A (fr) Preparations pharmaceutiques
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
JPS5386038A (en) Pharmaceutical composition for animal and application
IT1143009B (it) Composti farmaceutici ad azione antisecretiva e procedimento di preparazione
PH16443A (en) Substituted tetraazetricyclic compounds and their pharmaceutical compositions
IT8048615A0 (it) Pirazinobenzodiazepine loro preparazione e loro impiego come medicamenti
FI832519A7 (fi) Farmaseuttisia menetelmiä ja koostumuksia.
BE864124A (fr) Compositions pharmaceutiques analgesiques et anti-inflammatoires
BE869614A (fr) Combinaison medicamenteuse antithrombatique et procede pour sa preparation
IT8148952A0 (it) Amminoglucosidi ammidinati procedimento per loro preparazione e loro impiego come medicamenti
IT1143133B (it) Composizioni analgesiche e miotonolitiche
BE870265A (fr) Compositions pharmaceutiques anti-inflammatoires
IT1171361B (it) Amminociclopentanon-ammidi e procedimento per la loro preparazione e formulazione farmaceutica
FI832520A7 (fi) Farmaseuttisia menetelmiä ja koostumuksia.
MA19907A1 (fr) Procede de preparation de derives de la thiatriazine et utilisation de ceux-ci dans des compositions pharmaceutiques.
IT1134039B (it) Composizione farmaceutica ad azione prolungata
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
MA19893A1 (fr) Procede de preparation de derives de sulfamoylbenzophenone et utilisation de ceux-ci dans des compositions pharmaceutiques.
PT64998B (fr) Procede de preparation de nouvelles compositions pharmaceutiques et compositions obtenues par ce procede
PH15436A (en) 4-amino-2-piperidinoquinazoline derivatives and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRISTOL-MYERS CY

Effective date: 19930930